This mini-review examined blood glucose dynamics in ultramarathon runners. The study looked at how sugar levels changed during the race. It found that glucose levels rose in the first phase and then gradually declined in the second phase. In the third phase, variability increased, leading to more transient elevations. By the late stage of the race, blood glucose levels could not be fully explained by conventional factors like carbohydrate intake or exercise intensity. The review noted that direct evidence on this topic remains limited. Safety concerns were not reported in this analysis. Readers should understand that these findings describe patterns rather than proving specific causes. The main reason to be careful is that standard models do not fully predict these late-stage changes. This review suggests that continuous glucose monitors may provide a useful tool for identifying overall trends in glucose dynamics. These tools could support individualized nutritional strategies during ultramarathon running. Patients should discuss fueling plans with their care team before long events.
Ultramarathon running alters glucose dynamics in three distinct phasesGlucose spikes during ultramarathons may not match standard diet or exercise rules
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This mini-review examines glucose dynamics in ultramarathon runners, synthesizing available evidence on blood glucose changes during prolonged running. The authors describe a three-phase pattern: transient elevations in the first phase, a gradual decline in the second phase, and increased variability leading to transient elevations in the third phase. Notably, late-stage blood glucose increases cannot be fully explained by conventional determinants such as carbohydrate intake or exercise intensity.
The review highlights that direct evidence on glucose dynamics in ultramarathon runners remains limited, and the findings are based on a small body of research. The authors do not report sample sizes, comparators, or quantitative effect sizes, and no safety data are provided.
Despite these limitations, the authors suggest that continuous glucose monitors (CGMs) may provide a useful tool for identifying overall trends in glucose dynamics and supporting individualized nutritional strategies during ultramarathon running. Clinicians should interpret these findings cautiously given the limited evidence base.